UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Contribution of remnant cholesterol to cardiovascular risk

Journal of internal medicine, 2020-07, Vol.288 (1), p.116-127

2020

Volltextzugriff (PDF)

Chylomicronemia risk factors ranked by importance for the individual and community in 108 711 women and men

Journal of internal medicine, 2018-04, Vol.283 (4), p.392-404

2018

Volltextzugriff (PDF)

Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow‐up

Journal of internal medicine, 2011-07, Vol.270 (1), p.65-75

2011

Volltextzugriff (PDF)

Elevated remnant cholesterol appropriately reclassifies individuals who develop myocardial infarction

Atherosclerosis, 2022-08, Vol.355, p.46

2022

Volltextzugriff (PDF)

Active oils, comparator oils, and study populations as explanations for contrasting results of reduce-it vs. strength: copenhagen general population study mimicking trial designs

Atherosclerosis, 2021-08, Vol.331, p.e260-e261

2021

Volltextzugriff (PDF)

Statin use and reduced STEMI relative to non-STEMI: A nationwide study in denmark

Atherosclerosis, 2023-08, Vol.379, p.S41-S42

2023

Volltextzugriff (PDF)

Importance of APOB and non-HDL cholesterol for ischemic stroke is double that of LDL cholesterol

Atherosclerosis, 2022-08, Vol.355, p.17-18

2022

Volltextzugriff (PDF)

Obesity As A Causal Risk Factor For Aortic Valve Stenosis

Atherosclerosis, 2019-08, Vol.287, p.e69-e69

2019

Volltextzugriff (PDF)

Lipoprotein(A) And Risk Of Ischemic Stroke In The General Population

Atherosclerosis, 2019-08, Vol.287, p.e112-e112

2019

Volltextzugriff (PDF)

Apolipoprotein B and non-HDL-cholesterol better reflect residual risk than LDL-cholesterol in statin-treated patients with atherosclerosis

Atherosclerosis, 2021-08, Vol.331, p.e46-e46

2021

Volltextzugriff (PDF)

Dual elevated remnant cholesterol and C-reactive protein in myocardial infarction, atherosclerotic cardiovascular disease, and mortality

Atherosclerosis, 2023-08, Vol.379, p.S10

2023

Volltextzugriff (PDF)

Low-density lipoprotein cholesterol levels with the lowest all-cause mortality: 108,243 individuals in a contemporary population-based study

Atherosclerosis, 2020-12, Vol.315, p.e74-e74

2020

Volltextzugriff (PDF)

Quantification of LPA KIV-2 repeats with next generation sequencing technology

Atherosclerosis, 2020-12, Vol.315, p.e33-e33

2020

Volltextzugriff (PDF)

Small dense LDL cholesterol and ischemic stroke

Atherosclerosis, 2023-08, Vol.379, p.S44-S45

2023

Volltextzugriff (PDF)

Sex differences of lipoprotein(a) levels and associated risk of morbidity and mortality by age: The Copenhagen general population study

Atherosclerosis, 2022-08, Vol.355, p.62

2022

Volltextzugriff (PDF)

Unmet Need For Secondary Prevention In Individuals With Hyperlipoproteinemia(A): The Copenhagen General Population Study

Atherosclerosis, 2019-08, Vol.287, p.e112-e113

2019

Volltextzugriff (PDF)

Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regions

European journal of preventive cardiology, 2024-05

2024

Volltextzugriff (PDF)

Low HDL cholesterol to monitor long-term average elevated triglyceride-rich remnants: Four copenhagen cohorts including 120,828 individuals

Atherosclerosis, 2018-08, Vol.275, p.e96-e96

2018

Volltextzugriff (PDF)

Elevated lipoprotein(a) in mitral and aortic valve calcification and stenosis: The Copenhagen general population study

Atherosclerosis, 2021-08, Vol.331, p.e19-e20

2021

Volltextzugriff (PDF)

5131Unmet need for secondary prevention in individuals from the general population with increased lipoprotein(a): a contemporary population-based study

European heart journal, 2019-10, Vol.40 (Supplement_1)

2019

Volltextzugriff (PDF)

A managed multidisciplinary programme on multi-resistant Klebsiella pneumoniae in a Danish university hospital

BMJ quality & safety, 2013-11, Vol.22 (11), p.907-915

2013

Volltextzugriff (PDF)

Nonfasting hyperlipidemia and cardiovascular disease

Current drug targets, 2009-04, Vol.10 (4), p.328-335

2009

Volltextzugriff (PDF)

In reply to letter to editor by Reaven ‘Is insulin resistance the link between TG‐rich lipoproteins and excess death?’

Journal of internal medicine, 2011-12, Vol.270 (6), p.602-603

2011

Volltextzugriff (PDF)

In reply to letter to editor by Reaven ‘Is insulin resistance the link between TG-rich lipoproteins and excess death?’: Letter to the Editor

Journal of internal medicine, 2011-12, Vol.270 (6), p.602-603

2011

Volltextzugriff (PDF)

Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low LDL-C levels in a primary prevention setting

European heart journal, 2018-07, Vol.39 (27), p.2589-2596

2018

Volltextzugriff (PDF)

1 – 25 von 153

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(132)
Mit Volltextzugriff
(127)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Contribution of remnant cholesterol to cardiovascular risk

Chylomicronemia risk factors ranked by importance for the individual and community in 108 711 women and men

Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow‐up

Elevated remnant cholesterol appropriately reclassifies individuals who develop myocardial infarction

Active oils, comparator oils, and study populations as explanations for contrasting results of reduce-it vs. strength: copenhagen general population study mimicking trial designs

Statin use and reduced STEMI relative to non-STEMI: A nationwide study in denmark

Importance of APOB and non-HDL cholesterol for ischemic stroke is double that of LDL cholesterol

Obesity As A Causal Risk Factor For Aortic Valve Stenosis

Lipoprotein(A) And Risk Of Ischemic Stroke In The General Population

Apolipoprotein B and non-HDL-cholesterol better reflect residual risk than LDL-cholesterol in statin-treated patients with atherosclerosis

Dual elevated remnant cholesterol and C-reactive protein in myocardial infarction, atherosclerotic cardiovascular disease, and mortality

Low-density lipoprotein cholesterol levels with the lowest all-cause mortality: 108,243 individuals in a contemporary population-based study

Quantification of LPA KIV-2 repeats with next generation sequencing technology

Small dense LDL cholesterol and ischemic stroke

Sex differences of lipoprotein(a) levels and associated risk of morbidity and mortality by age: The Copenhagen general population study

Unmet Need For Secondary Prevention In Individuals With Hyperlipoproteinemia(A): The Copenhagen General Population Study

Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regions

Low HDL cholesterol to monitor long-term average elevated triglyceride-rich remnants: Four copenhagen cohorts including 120,828 individuals

Elevated lipoprotein(a) in mitral and aortic valve calcification and stenosis: The Copenhagen general population study

5131Unmet need for secondary prevention in individuals from the general population with increased lipoprotein(a): a contemporary population-based study

A managed multidisciplinary programme on multi-resistant Klebsiella pneumoniae in a Danish university hospital

Nonfasting hyperlipidemia and cardiovascular disease

In reply to letter to editor by Reaven ‘Is insulin resistance the link between TG‐rich lipoproteins and excess death?’

In reply to letter to editor by Reaven ‘Is insulin resistance the link between TG-rich lipoproteins and excess death?’: Letter to the Editor

Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low LDL-C levels in a primary prevention setting

Suchergebnisse filtern